JP2006525315A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525315A5
JP2006525315A5 JP2006507485A JP2006507485A JP2006525315A5 JP 2006525315 A5 JP2006525315 A5 JP 2006525315A5 JP 2006507485 A JP2006507485 A JP 2006507485A JP 2006507485 A JP2006507485 A JP 2006507485A JP 2006525315 A5 JP2006525315 A5 JP 2006525315A5
Authority
JP
Japan
Prior art keywords
dosage form
active agent
agent component
barrier
transdermal dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525315A (ja
Filing date
Publication date
Priority claimed from US10/744,966 external-priority patent/US20040219195A1/en
Application filed filed Critical
Publication of JP2006525315A publication Critical patent/JP2006525315A/ja
Publication of JP2006525315A5 publication Critical patent/JP2006525315A5/ja
Pending legal-status Critical Current

Links

JP2006507485A 2003-04-30 2004-03-23 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形 Pending JP2006525315A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46724303P 2003-04-30 2003-04-30
US10/744,966 US20040219195A1 (en) 2003-04-30 2003-12-23 Abuse-resistant transdermal dosage form
PCT/US2004/008856 WO2004098568A2 (en) 2003-04-30 2004-03-23 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012064165A Division JP2012140453A (ja) 2003-04-30 2012-03-21 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形

Publications (2)

Publication Number Publication Date
JP2006525315A JP2006525315A (ja) 2006-11-09
JP2006525315A5 true JP2006525315A5 (cg-RX-API-DMAC7.html) 2007-05-10

Family

ID=33313652

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006507485A Pending JP2006525315A (ja) 2003-04-30 2004-03-23 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形
JP2012064165A Pending JP2012140453A (ja) 2003-04-30 2012-03-21 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012064165A Pending JP2012140453A (ja) 2003-04-30 2012-03-21 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形

Country Status (9)

Country Link
US (2) US20040219195A1 (cg-RX-API-DMAC7.html)
EP (1) EP1651196B1 (cg-RX-API-DMAC7.html)
JP (2) JP2006525315A (cg-RX-API-DMAC7.html)
AT (1) ATE423551T1 (cg-RX-API-DMAC7.html)
AU (2) AU2004237579A1 (cg-RX-API-DMAC7.html)
CA (1) CA2523709A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004019653D1 (cg-RX-API-DMAC7.html)
ES (1) ES2322154T3 (cg-RX-API-DMAC7.html)
WO (1) WO2004098568A2 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409945A (pt) 2003-04-30 2006-04-25 Purdue Pharma Lp forma de dosagem resistente à alteração
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
CA2611224C (en) * 2005-06-10 2014-01-21 3M Innovative Properties Company Method for handling adhesive laminate sections
US9522188B2 (en) * 2005-12-13 2016-12-20 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
US7740879B2 (en) * 2006-01-17 2010-06-22 Harrogate Holdings Abuse resistant transdermal drug delivery patch
DE102006025282A1 (de) * 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
US20080140024A1 (en) * 2006-12-08 2008-06-12 Yoseph Yaacobi Drug delivery device
US9700552B2 (en) * 2008-02-28 2017-07-11 Syntropharma Limited Pharmaceutical compositions for treatment of addiction
JP5386205B2 (ja) * 2009-03-19 2014-01-15 リンテック株式会社 経皮吸収型貼付剤
JP2013524275A (ja) * 2010-04-03 2013-06-17 ドシ，プラフル 薬剤を含む医療機器、その製造方法とその使用方法
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
WO2013148506A1 (en) * 2012-03-30 2013-10-03 3M Innovative Properties Company Urea-based and urethane-based pressure sensitive adhesive blends
US9950106B2 (en) 2012-12-05 2018-04-24 Cook Medical Technologies Llc Antimicrobial barrier device
RS58759B1 (sr) * 2014-01-22 2019-06-28 4P Therapeutics Transdermalni sistemi koji onemogućavaju zloupotrebu i pogrešnu upotrebu
WO2016099986A2 (en) 2014-12-18 2016-06-23 3M Innovative Properties Company Methods of handling adhesive laminate patches
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
EP3247262A1 (en) * 2015-01-23 2017-11-29 Marcio Marc Abreu Apparatus and method for skin treatment
CN110470607B (zh) * 2018-05-09 2021-12-07 江苏集萃智能液晶科技有限公司 一种检测混合溶液中亲水性有机溶剂含量的方法
WO2020008370A1 (en) * 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal patch

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1602344A (en) * 1924-01-09 1926-10-05 Eagle Peter Medicating compress
US2807262A (en) * 1952-12-10 1957-09-24 Robert B Lew Perforated plastic adhesive tape bandage
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
US4457933A (en) * 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4539256A (en) * 1982-09-09 1985-09-03 Minnesota Mining And Manufacturing Co. Microporous sheet material, method of making and articles made therewith
US4693776A (en) * 1985-05-16 1987-09-15 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4743249A (en) * 1986-02-14 1988-05-10 Ciba-Geigy Corp. Dermal and transdermal patches having a discontinuous pattern adhesive layer
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
JPH0538010Y2 (cg-RX-API-DMAC7.html) * 1987-03-17 1993-09-27
KR970008118B1 (ko) * 1987-07-09 1997-05-21 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 피부 침투성 치료 시스템
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5176917A (en) * 1989-03-15 1993-01-05 Lts Lohmann Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
CA2173855C (en) * 1993-10-29 2007-06-26 Mieczyslaw H. Mazurek Pressure-sensitive adhesives having microstructured surfaces
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
WO1997004835A1 (de) * 1995-07-28 1997-02-13 Novartis Ag Transdermales system
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US20020110585A1 (en) * 1999-11-30 2002-08-15 Godbey Kristin J. Patch therapeutic agent delivery device having texturized backing
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
KR100904158B1 (ko) * 2001-03-16 2009-06-23 알자 코포레이션 펜타닐 투여용 경피성 패치
DK2316439T3 (en) * 2001-05-01 2015-08-10 Euro Celtique Sa Abuse-proof transdermal systems containing opioids
CA2496454A1 (en) * 2002-04-23 2003-11-06 Alza Corporation Transdermal analgesic systems with reduced abuse potential
ES2323127T3 (es) * 2002-08-20 2009-07-07 Euro-Celtique S.A. Forma posologica transdermica que comprende un agente activo y una forma de sal y una forma de base libre de un antagonista.
US20040109886A1 (en) * 2002-08-27 2004-06-10 Larry Rigby Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
BRPI0409945A (pt) * 2003-04-30 2006-04-25 Purdue Pharma Lp forma de dosagem resistente à alteração
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
DE102004038179A1 (de) * 2004-08-06 2006-03-16 Daimlerchrysler Ag Verfahren zur Herstellung einer thermisch beschichteten Zylinderlauffläche mit einer Einfuhrfase

Similar Documents

Publication Publication Date Title
JP2006525316A5 (cg-RX-API-DMAC7.html)
del Consuelo et al. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl
ES2245649T3 (es) Un sistema de entrega de farmaco dual adhesivo transdermico.
TWI435737B (zh) 經皮遞送醫藥化合物的方法及其組成物
JP6525165B2 (ja) 乱用および誤用抑止経皮システム
CL2014001029A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion extendida que comprende una formulacion matricial que comprende un agente activo en forma de comprimido o multiparticulado; agente activo es un analgesico opioide; y uso en el tratamiento del dolor. (div. sol. 499-2012).
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
WO2005112984A3 (en) Apparatus and method for transdermal delivery of parathyroid hormone agents
TR200200562T2 (tr) Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
WO2008157103A3 (en) Modified release solid or semi-solid dosage forms
DE602004032149D1 (de) Oros-push-stick für die kontrollierte abgabe von wirkstoffen
KR101050002B1 (ko) 다층 경점막성 치료시스템
AU2006216955A1 (en) Transdermal systems having control delivery system
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
WO2004098568A3 (en) Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
JP2005002009A (ja) フェンタニル含有口腔粘膜貼付剤
WO2004012676A3 (en) Drug-loaded biological material chemically treated with genipin
NO20031409D0 (no) Ionestyrkeuavhengig farmasöytiske preparat med langvarig frigivelse
WO2001013898A3 (en) Pharmaceutical formulations with different release times
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
US20070248657A1 (en) Multi-compartment transdermal pain control device
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
JP2024543149A (ja) 経口マイクロニードルパッチ
RU2434631C2 (ru) Трансдермальная терапевтическая система для летучих и/или термолабильных веществ
WO2005079750A3 (en) Films for use as dosage forms